Minimal residual disease in multiple myeloma: Benefits of flow cytometryIrina Galtseva, Л. П. Менделеева, Yulia Davydova et al.|International Journal of Laboratory Hematology|2017Cited by 10
Multiple myeloma: Maintenance therapy after autologous hematopoietic stem cell transplantation, depending on minimal residual diseaseM. V. Solovyev, Savchenko Vg, Л. П. Менделеева et al.|Terapevticheskii arkhiv|2017Cited by 4
Absolute numbers of peripheral blood CD34+ hematopoietic stem cells prior to a leukapheresis procedure as a parameter predicting the efficiency of stem cell collectionIrina Galtseva, Savchenko Vg, Larisa A. Kuzmina et al.|Terapevticheskii arkhiv|2017Cited by 3
FLOW CYTOMETRY IN THE DIAGNOSIS AND MONITORING OF MINIMAL RESIDUAL DISEASE IN MULTIPLE MYELOMAIrina Galtseva, Л. П. Менделеева, Yulia Davydova et al.|Oncohematology|2017Cited by 2
STUDY OF MINIMAL RESIDUAL DISEASE BY MULTICOLOR FLOW CYTOMETRY IN MULTIPLE MYELOMA AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATIONIrina Galtseva, Savchenko Vg, Л. П. Менделеева et al.|Oncohematology|2017Cited by 2